- Home
- GHRS vs KRNY Comparison
GHRS vs KRNY Comparison
Compare GHRS & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- KRNY
- Stock Information
- Founded
- GHRS 2018
- KRNY 1884
- Country
- GHRS Ireland
- KRNY United States
- Employees
- GHRS N/A
- KRNY N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- KRNY Savings Institutions
- Sector
- GHRS Health Care
- KRNY Finance
- Exchange
- GHRS Nasdaq
- KRNY Nasdaq
- Market Cap
- GHRS 470.3M
- KRNY 436.9M
- IPO Year
- GHRS 2021
- KRNY 2005
- Fundamental
- Price
- GHRS $9.62
- KRNY $8.19
- Analyst Decision
- GHRS Strong Buy
- KRNY Hold
- Analyst Count
- GHRS 3
- KRNY 1
- Target Price
- GHRS $35.67
- KRNY $7.00
- AVG Volume (30 Days)
- GHRS 71.7K
- KRNY 364.8K
- Earning Date
- GHRS 11-14-2024
- KRNY 10-24-2024
- Dividend Yield
- GHRS N/A
- KRNY 5.37%
- EPS Growth
- GHRS N/A
- KRNY N/A
- EPS
- GHRS N/A
- KRNY N/A
- Revenue
- GHRS N/A
- KRNY $128,413,999.00
- Revenue This Year
- GHRS N/A
- KRNY N/A
- Revenue Next Year
- GHRS N/A
- KRNY $28.55
- P/E Ratio
- GHRS N/A
- KRNY N/A
- Revenue Growth
- GHRS N/A
- KRNY N/A
- 52 Week Low
- GHRS $5.05
- KRNY $5.28
- 52 Week High
- GHRS $14.99
- KRNY $9.46
- Technical
- Relative Strength Index (RSI)
- GHRS 58.95
- KRNY 62.26
- Support Level
- GHRS $8.50
- KRNY $7.95
- Resistance Level
- GHRS $11.09
- KRNY $8.59
- Average True Range (ATR)
- GHRS 0.90
- KRNY 0.29
- MACD
- GHRS 0.14
- KRNY 0.00
- Stochastic Oscillator
- GHRS 56.20
- KRNY 76.88
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.